Concordia International Corp. Announces Addition of Pharmaceutical Industry Expert to its Board of Directors
(WorldNews Canada)

MISSISSAUGA, ON, Oct. 15, 2018/CNW/ - Concordia International Corp. (`Concordia` or the `Company`) (TSX: CXR), an international specialty pharmaceutical company focused on becoming a leader in European specialty, off-patent medicines, today announced that it has appointed pharmaceutical industry expert Frances Cloudto its board of directors. Ms. Cloud`s appointment will take effect on November 1, 2018. `We are delighted to welcome Frances and believe that she will provide crucial experience to our board and Company,` said Graeme Duncan, Chief Executive Officer of Concordia. `Her expertise as a thought leader in the complex and dynamic European pharmaceutical industry will be particularly...